Explainer: Why Himachal’s pharma sector is facing a trust crisis
1.39 per cent of the samples drawn by the state drug authorities have failed quality parameters in the last three years. Manufacturers may downplay the concerns, but there is no room for laxity
ACCLAIMED as Asia’s pharmaceutical hub with 651 small and big firms, Himachal Pradesh accounts for every third drug in the domestic market and 35 per cent of the national output. Its trust and credibility quotient, however, is under strain as in the last three years, 1.39 per cent of the drug samples drawn by the state drug authorities have failed quality parameters.


